Neves, 115 patient vitamin D sufficiency study: 57% lower mortality [p=0.05] and 20% higher ICU admission [p=0.81] https://c19p.org/neves2
copied to clipboard
Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19
et al., Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2022.05.027
Retrospective 115 hospitalized patients in Brazil, showing lower mortality with higher vitamin D levels. Adjusted results are only provided for vitamin D as a continuous variable.
|
risk of death, 57.1% lower, RR 0.43, p = 0.046, high D levels (≥50nmol/L) 12 of 87 (13.8%), low D levels (<50nmol/L) 9 of 28 (32.1%), NNT 5.4.
|
|
risk of ICU admission, 19.5% higher, RR 1.20, p = 0.81, high D levels (≥50nmol/L) 26 of 87 (29.9%), low D levels (<50nmol/L) 7 of 28 (25.0%).
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
This study is excluded in the after exclusion results of meta
analysis:
excessive unadjusted differences between groups.
Neves et al., 6/14/2022, retrospective, Brazil, peer-reviewed, mean age 62.1, 7 authors, study period July 2020 - December 2020.
Contact:
fabioneves@ufscar.br.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.